Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years - Results from the BEVORDEX randomized clinical trial of bevacizumab versus dexamethasone implants for diabetic macular edema

Mehta Hemal; Fraser-Bell Samantha; Vuong Nguyen; Gillies Mark C.

首页> 外文期刊>Investigative ophthalmology & visual science >Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years - Results from the BEVORDEX randomized clinical trial of bevacizumab versus dexamethasone implants for diabetic macular edema

【24h】

Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years - Results from the BEVORDEX randomized clinical trial of bevacizumab versus dexamethasone implants for diabetic macular edema

机译：12周的短期视觉增益与2年的长期视觉增益相关 - Bevordex随机化临床试验的贝伐单抗与糖尿病性黄斑水肿的地塞米松植入物

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2017年第8期|共2页
作者
Mehta Hemal; Fraser-Bell Samantha; Vuong Nguyen; Gillies Mark C.;
展开▼
作者单位

Royal Free London NHS Fdn Trust Ophthalmol London England;

Univ Sydney Save Sight Inst Macular Res Grp Sydney NSW Australia;

Univ Sydney Save Sight Inst Macular Res Grp Sydney NSW Australia;

Univ Sydney Save Sight Inst Macular Res Grp Sydney NSW Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献

1. Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years - Results from the BEVORDEX randomized clinical trial of bevacizumab versus dexamethasone implants for diabetic macular edema [J] . Mehta Hemal, Fraser-Bell Samantha, Vuong Nguyen, Investigative ophthalmology & visual science . 2017,第8期

机译：12周的短期视觉增益与2年的长期视觉增益相关 - Bevordex随机化临床试验的贝伐单抗与糖尿病性黄斑水肿的地塞米松植入物
2. Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedema [J] . Mehta Hemal, Fraser-Bell Samantha, Vuong Nguyen, British journal of ophthalmology . 2018,第4期

机译：12周内的短期视觉增益与2年的长期视觉增益相关：Bevordex随机临床试验的结果对贝伐单抗与糖尿病性黄斑水肿的地塞米松植入物
3. Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedema [J] . Mehta Hemal, Fraser-Bell Samantha, Vuong Nguyen, British journal of ophthalmology . 2018,第4期

机译：12周内的短期视觉增益与2年的长期视觉增益相关：Bevordex随机临床试验的结果对贝伐单抗与糖尿病性黄斑水肿的地塞米松植入物
4. Long-term comparison of bone regeneration between immediate and conventional loading of implants placed in fresh extracted sockets in periodontally compromised patients: 6-year randomized clinical trial. [D] . Alqahtani, Nabeeh Abdullah. 2014

机译：在牙周病患者中，在新鲜的拔牙窝中立即和常规负载的种植体之间进行骨再生的长期比较：6年随机临床试验。
5. Combination of Intravitreal Bevacizumab and Topical Dorzolamide versus Intravitreal Bevacizumab Alone for Diabetic Macular Edema: A Randomized Contralateral Clinical Trial [O] . Farhad Fazel, Hossein Nikpour, Mohsen Pourazizi 2020

机译：玻璃体腔注射贝伐单抗和局部用多佐唑胺与单独玻璃体腔注射贝伐单抗联合治疗糖尿病性黄斑水肿：随机对侧临床试验
6. Vision-Related Quality of Life Outcomes in the BEVORDEX Study: A Clinical Trial Comparing Ozurdex Sustained Release Dexamethasone Intravitreal Implant and Bevacizumab Treatment for Diabetic Macular Edema [O] . Christine Aroney, Samantha Fraser-Bell, Ecosse L. Lamoureux, 2016

机译：Bevordex研究中的视觉相关质量结果：临床试验，比较Ozurdex持续释放地塞米松玻璃体植入物和Bevacizumab治疗糖尿病黄斑水肿

Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years - Results from the BEVORDEX randomized clinical trial of bevacizumab versus dexamethasone implants for diabetic macular edema

著录项

相似文献

相关主题

期刊订阅